Stock DNA
Chemicals: Specialty
CAD 8 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
0.66
-35.33%
0.16
Revenue and Profits:
Net Sales:
252 Million
(Quarterly Results - Mar 2025)
Net Profit:
19 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-63.64%
0%
-63.64%
6 Months
-77.78%
0%
-77.78%
1 Year
-90.48%
0%
-90.48%
2 Years
-94.12%
0%
-94.12%
3 Years
-95.51%
0%
-95.51%
4 Years
-96.67%
0%
-96.67%
5 Years
-66.67%
0%
-66.67%
Royal Helium Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
4.90%
EBIT Growth (5y)
-33.82%
EBIT to Interest (avg)
-2.55
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.66
Sales to Capital Employed (avg)
0.00
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.03%
ROCE (avg)
0
ROE (avg)
6.37%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.16
EV to EBIT
-3.37
EV to EBITDA
-4.55
EV to Capital Employed
0.49
EV to Sales
17.40
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-14.67%
ROE (Latest)
-35.33%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot : Dec 2024
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.03%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Mar'25 - YoY
Mar'25
Mar'24
Change(%)
Net Sales
251.90
204.70
23.06%
Operating Profit (PBDIT) excl Other Income
48.70
43.00
13.26%
Interest
1.50
1.80
-16.67%
Exceptional Items
0.00
0.00
Consolidate Net Profit
19.00
15.50
22.58%
Operating Profit Margin (Excl OI)
102.20%
109.20%
-0.70%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2025 is 23.06% vs 0.00% in Mar 2024
Consolidated Net Profit
YoY Growth in quarter ended Mar 2025 is 22.58% vs 1,509.09% in Mar 2024
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
0.10
0.00
Operating Profit (PBDIT) excl Other Income
-7.10
-4.20
-69.05%
Interest
2.60
0.00
Exceptional Items
-0.00
0.00
Consolidate Net Profit
-11.00
-4.40
-150.00%
Operating Profit Margin (Excl OI)
-82,071.50%
0.00%
-8,207.15%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is 0.00% vs 0.00% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is -150.00% vs 13.73% in Dec 2022
About Royal Helium Ltd. 
Royal Helium Ltd.
Chemicals: Specialty
Royal Helium Ltd., formerly RHC Capital Corp, is a Canada-based helium leaseholder company. The Company focuses on the exploration and development of primary helium in southern Saskatchewan.
Company Coordinates 
Company Details
Suite 602 - 224 4th Avenue S , SASKATOON SK : S7K 5M5
Registrar Details






